Regulation of invadopodia by the tumor microenvironment

Cell Adhesion and Migration

Volumn 8, Issue 3, 2014, Pages 226-235

  Gould, Christine M ^a   Courtneidge, Sara A ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Hypoxia; Invadopodia; Metastasis; Podosomes; Tumor microenvironment

Indexed keywords

CD147 ANTIGEN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE A; NOTCH RECEPTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PYRUVATE KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 1; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AUTOCRINE EFFECT; CANCER CELL; CELL HYPOXIA; CELL INTERACTION; CELL MEMBRANE; CELL METABOLISM; EPITHELIAL MESENCHYMAL TRANSITION; GLYCOLYSIS; HUMAN; INTRACELLULAR SIGNALING; INVADOPODIUM; METASTASIS; OXIDATIVE PHOSPHORYLATION; PARACRINE SIGNALING; PH; PODOSOME; REGULATORY MECHANISM; REVIEW; STROMA; TUMOR INVASION; TUMOR MICROENVIRONMENT; ANIMAL; CELL MOTION; EXTRACELLULAR MATRIX; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL MOVEMENT; EXTRACELLULAR MATRIX; HUMANS; NEOPLASM INVASIVENESS; TUMOR MICROENVIRONMENT;

EID: 84901433450     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.28346     Document Type: Review

References (120)

1. Weber CE, Kuo PC. The tumor microenvironment. Surg Oncol 2012; 21:172-7; PMID:21963199; http://dx.doi.org/10.1016/j.suronc.2011.09.001
2. Hu M, Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genet Dev 2008; 18:27-34; PMID:18282701; http://dx.doi.org/10.1016/j.gde.2007.12.006
3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
4. Flaberg E, Markasz L, Petranyi G, Stuber G, Dicso F, Alchihabi N, Oláh È, Csízy I, Józsa T, Andrén O, et al. High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. Int J Cancer 2011; 128:2793-802; PMID:20715102; http://dx.doi.org/10.1002/ijc.25612
5. Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 2011; 10:417-27; PMID:21629292; http://dx.doi.org/10.1038/nrd3455
6. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3:401-10; PMID:12778130; http://dx.doi.org/10.1038/nrc1093
7. Du XL, Jiang T, Zhao WB, Wang F, Wang GL, Cui M, Wen ZQ. Gene alterations in tumor-associated endothelial cells from endometrial cancer. Int J Mol Med 2008; 22:619-32; PMID:18949382
8. Cooke VG, LeBleu VS, Keskin D, Khan Z, O'Connell JT, Teng Y, Duncan MB, Xie L, Maeda G, Vong S, et al. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell 2012; 21:66-81; PMID:22264789; http://dx.doi.org/10.1016/j.ccr.2011.11.024
9. Polyak K, Haviv I, Campbell IG. Co-evolution of tumor cells and their microenvironment. Trends Genet 2009; 25:30-8; PMID:19054589; http://dx.doi.org/10.1016/j.tig.2008.10.012
10. Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N, Thompson JC, Caserta E, Wang H, Chong JL, et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 2009; 461:1084-91; PMID:19847259; http://dx.doi.org/10.1038/nature08486
11. Wallace JA, Li F, Leone G, Ostrowski MC. Pten in the breast tumor microenvironment: modeling tumor-stroma coevolution. Cancer Res 2011; 71:1203-7; PMID:21303970; http://dx.doi.org/10.1158/0008-5472.CAN-10-3263
12. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650-9; PMID:3537791; http://dx.doi.org/10.1056/NEJM198612253152606
13. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141:39-51; PMID:20371344; http://dx.doi.org/10.1016/j.cell.2010.03.014
14. Yao S, Zhu Y, Chen L. Advances in targeting cell surface signalling molecules for immune modulation. Nat Rev Drug Discov 2013; 12:130-46; PMID:23370250; http://dx.doi.org/10.1038/nrd3877
15. Linder S, Wiesner C, Himmel M. Degrading devices: invadosomes in proteolytic cell invasion. Annu Rev Cell Dev Biol 2011; 27:185-211; PMID:21801014; http://dx.doi.org/10.1146/annurev-cellbio-092910-154216
16. Sabeh F, Shimizu-Hirota R, Weiss SJ. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J Cell Biol 2009; 185:11-9; PMID:19332889; http://dx.doi.org/10.1083/jcb.200807195
17. Sahai E. Mechanisms of cancer cell invasion. Curr Opin Genet Dev 2005; 15:87-96; PMID:15661538; http://dx.doi.org/10.1016/j.gde.2004.12.002
18. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003; 3:921-30; PMID:14737122; http://dx.doi.org/10.1038/nrc1231
19. Yamaguchi H. Pathological roles of invadopodia in cancer invasion and metastasis. Eur J Cell Biol 2012; 91:902-7; PMID:22658792; http://dx.doi.org/10.1016/j.ejcb.2012.04.005
20. Murphy DA, Courtneidge SA. The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol 2011; 12:413-26; PMID:21697900; http://dx.doi.org/10.1038/nrm3141
21. Caldieri G, Ayala I, Attanasio F, Buccione R. Cell and molecular biology of invadopodia. Int Rev Cell Mol Biol 2009; 275:1-34; PMID:19491051; http://dx.doi.org/10.1016/S1937-6448(09)75001-4
22. Destaing O, Block MR, Planus E, Albiges-Rizo C. Invadosome regulation by adhesion signaling. Curr Opin Cell Biol 2011; 23:597-606; PMID:21550788; http://dx.doi.org/10.1016/j.ceb.2011.04.002
23. Hoshino D, Branch KM, Weaver AM. Signaling inputs to invadopodia and podosomes. J Cell Sci 2013; 126:2979-89; PMID:23843616; http://dx.doi.org/10.1242/jcs.079475
24. Mueller S, Artym VV, Kelly T. Invadopodia: Interface for Invasion. In: Dylan Edwards GH-H, Francesco Blasi, and Boonie F. Sloane, ed. The Cancer Degradome: Springer New York, 2008:403-31.
25. Linder S, Nelson D, Weiss M, Aepfelbacher M. Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc Natl Acad Sci U S A 1999; 96:9648-53; PMID:10449748; http://dx.doi.org/10.1073/pnas.96.17.9648
26. Burns S, Thrasher AJ, Blundell MP, Machesky L, Jones GE. Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood 2001; 98:1142-9; PMID:11493463; http://dx.doi.org/10.1182/blood.V98.4.1142
27. Destaing O, Saltel F, Géminard JC, Jurdic P, Bard F. Podosomes display actin turnover and dynamic self-organization in osteoclasts expressing actin-green fluorescent protein. Mol Biol Cell 2003; 14:407-16; PMID:12589043; http://dx.doi.org/10.1091/mbc.E02-07-0389
28. Lauzier A, Charbonneau M, Harper K, Jilaveanu-Pelmus M, Dubois CM. Formation of invadopodia-like structures by synovial cells promotes cartilage breakdown in collagen-induced arthritis: involvement of the protein tyrosine kinase Src. Arthritis Rheum 2011; 63:1591-602; PMID:21337539; http://dx.doi.org/10.1002/art.30305
29. Cejudo-Martin P, Courtneidge SA. Podosomal proteins as causes of human syndromes: a role in craniofacial development? Genesis 2011; 49:209-21; PMID:21328520; http://dx.doi.org/10.1002/dvg.20732
30. Burgstaller G, Gimona M. Podosome-mediated matrix resorption and cell motility in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2005; 288:H3001-5; PMID:15695563; http://dx.doi.org/10.1152/ajpheart.01002.2004
31. Moreau V, Tatin F, Varon C, Génot E. Actin can reorganize into podosomes in aortic endothelial cells, a process controlled by Cdc42 and RhoA. Mol Cell Biol 2003; 23:6809-22; PMID:12972601; http://dx.doi.org/10.1128/MCB.23.19.6809-6822.2003
32. Tatin F, Varon C, Génot E, Moreau V. A signalling cascade involving PKC, Src and Cdc42 regulates podosome assembly in cultured endothelial cells in response to phorbol ester. J Cell Sci 2006; 119:769-81; PMID:16449321; http://dx.doi.org/10.1242/jcs.02787
33. Varon C, Tatin F, Moreau V, Van Obberghen-Schilling E, Fernandez-Sauze S, Reuzeau E, Kramer I, Génot E. Transforming growth factor beta induces rosettes of podosomes in primary aortic endothelial cells. Mol Cell Biol 2006; 26:3582-94; PMID:16611998; http://dx.doi.org/10.1128/MCB.26.9.3582-3594.2006
34. Gimona M, Buccione R, Courtneidge SA, Linder S. Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol 2008; 20:235-41; PMID:18337078; http://dx.doi.org/10.1016/j.ceb.2008.01.005
35. Klemke RL. Trespassing cancer cells: 'fingerprinting' invasive protrusions reveals metastatic culprits. Curr Opin Cell Biol 2012; 24:662-9; PMID:22980730; http://dx.doi.org/10.1016/j.ceb.2012.08.005
36. Sharma VP, Eddy R, Entenberg D, Kai M, Gertler FB, Condeelis J. Tks5 and SHIP2 regulate invadopodium maturation, but not initiation, in breast carcinoma cells. Curr Biol 2013; 23:2079-89; PMID:24206842; http://dx.doi.org/10.1016/j.cub.2013.08.044
37. Seals DF, Azucena EF Jr., Pass I, Tesfay L, Gordon R, Woodrow M, Resau JH, Courtneidge SA. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell 2005; 7:155-65; PMID:15710328; http://dx.doi.org/10.1016/j.ccr.2005.01.006
38. Buschman MD, Bromann PA, Cejudo-Martin P, Wen F, Pass I, Courtneidge SA. The novel adaptor protein Tks4 (SH3PXD2B) is required for functional podosome formation. Mol Biol Cell 2009; 20:1302-11; PMID:19144821; http://dx.doi.org/10.1091/mbc.E08-09-0949
39. Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 1999; 18:4440-9; PMID:10442635; http://dx.doi.org/10.1038/sj.onc.1202827
40. Chen WT, Wang JY. Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization. Ann N Y Acad Sci 1999; 878:361-71; PMID:10415741; http://dx.doi.org/10.1111/j.1749-6632.1999.tb07695.x
41. Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, Eddy R, Miki H, Takenawa T, et al. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol 2005; 168:441-52; PMID:15684033; http://dx.doi.org/10.1083/jcb.200407076
42. Bravo-Cordero JJ, Oser M, Chen X, Eddy R, Hodgson L, Condeelis J. A novel spatiotemporal RhoC activation pathway locally regulates cofilin activity at invadopodia. Curr Biol 2011; 21:635-44; PMID:21474314; http://dx.doi.org/10.1016/j.cub.2011.03.039
43. Beaty BT, Sharma VP, Bravo-Cordero JJ, Simpson MA, Eddy RJ, Koleske AJ, Condeelis J. β1 integrin regulates Arg to promote invadopodial maturation and matrix degradation. Mol Biol Cell 2013; 24:1661-75, S1-11; PMID:23552693; http://dx.doi.org/10.1091/mbc.E12-12-0908
44. Attanasio F, Caldieri G, Giacchetti G, van Horssen R, Wieringa B, Buccione R. Novel invadopodia components revealed by differential proteomic analysis. Eur J Cell Biol 2011; 90:115-27; PMID:20609496; http://dx.doi.org/10.1016/j.ejcb.2010.05.004
45. Artym VV, Matsumoto K, Mueller SC, Yamada KM. Dynamic membrane remodeling at invadopodia differentiates invadopodia from podosomes. Eur J Cell Biol 2011; 90:172-80; PMID:20656375; http://dx.doi.org/10.1016/j.ejcb.2010.06.006
46. Quintavalle M, Elia L, Price JH, Heynen-Genel S, Courtneidge SA. A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion. Sci Signal 2011; 4:ra49; PMID:21791703; http://dx.doi.org/10.1126/scisignal.2002032
47. Winograd-Katz SE, Brunner MC, Mirlas N, Geiger B. Analysis of the signaling pathways regulating Src-dependent remodeling of the actin cytoskeleton. Eur J Cell Biol 2011; 90:143-56; PMID:20719402; http://dx.doi.org/10.1016/j.ejcb.2010.07.006
48. Diaz B, Shani G, Pass I, Anderson D, Quintavalle M, Courtneidge SA. Tks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formation. Sci Signal 2009; 2:ra53; PMID:19755709; http://dx.doi.org/10.1126/scisignal.2000368
49. Yamaguchi H, Yoshida S, Muroi E, Yoshida N, Kawamura M, Kouchi Z, Nakamura Y, Sakai R, Fukami K. Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation. J Cell Biol 2011; 193:1275-88; PMID:21708979; http://dx.doi.org/10.1083/jcb.201009126
50. Weaver AM. Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis 2006; 23:97-105; PMID:16830222; http://dx.doi.org/10.1007/s10585-006-9014-1
51. Yamaguchi H, Wyckoff J, Condeelis J. Cell migration in tumors. Curr Opin Cell Biol 2005; 17:559-64; PMID:16098726; http://dx.doi.org/10.1016/j.ceb.2005.08.002
52. Eckert MA, Lwin TM, Chang AT, Kim J, Danis E, Ohno-Machado L, Yang J. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell 2011; 19:372-86; PMID:21397860; http://dx.doi.org/10.1016/j.ccr.2011.01.036
53. Gligorijevic B, Wyckoff J, Yamaguchi H, Wang Y, Roussos ET, Condeelis J. N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J Cell Sci 2012; 125:724-34; PMID:22389406; http://dx.doi.org/10.1242/jcs.092726
54. Blouw B, Seals DF, Pass I, Diaz B, Courtneidge SA. A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo. Eur J Cell Biol 2008; 87:555-67; PMID:18417249; http://dx.doi.org/10.1016/j.ejcb.2008.02.008
55. Clark ES, Brown B, Whigham AS, Kochaishvili A, Yarbrough WG, Weaver AM. Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon. Oncogene 2009; 28:431-44; PMID:18931703; http://dx.doi.org/10.1038/onc.2008.389
56. Li CM, Chen G, Dayton TL, Kim-Kiselak C, Hoersch S, Whittaker CA, Bronson RT, Beer DG, Winslow MM, Jacks T. Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma. Genes Dev 2013; 27:1557-67; PMID:23873940; http://dx.doi.org/10.1101/gad.222745.113
57. Brentnall TA. Arousal of cancer-associated stromal fibroblasts: palladin-activated fibroblasts promote tumor invasion. Cell Adh Migr 2012; 6:488-94; PMID:23076142; http://dx.doi.org/10.4161/cam.21453
58. Brentnall TA, Lai LA, Coleman J, Bronner MP, Pan S, Chen R. Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion. PLoS One 2012; 7:e30219; PMID:22291919; http://dx.doi.org/10.1371/journal.pone.0030219
59. Goicoechea SM, García-Mata R, Staub J, Valdivia A, Sharek L, McCulloch CG, Hwang RF, Urrutia R, Yeh JJ, Kim HJ, et al. Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts. Oncogene 2013; (Forthcoming); PMID:23524582; http://dx.doi.org/10.1038/onc.2013.68
60. Nakahara H, Otani T, Sasaki T, Miura Y, Takai Y, Kogo M. Involvement of Cdc42 and Rac small G proteins in invadopodia formation of RPMI7951 cells. Genes Cells 2003; 8:1019-27; PMID:14750956; http://dx.doi.org/10.1111/j.1365-2443.2003.00695.x
61. Albiges-Rizo C, Destaing O, Fourcade B, Planus E, Block MR. Actin machinery and mechanosensitivity in invadopodia, podosomes and focal adhesions. J Cell Sci 2009; 122:3037-49; PMID:19692590; http://dx.doi.org/10.1242/jcs.052704
62. Díaz B, Yuen A, Iizuka S, Higashiyama S, Courtneidge SA. Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia. J Cell Biol 2013; 201:279-92; PMID:23589494; http://dx.doi.org/10.1083/jcb.201209151
63. Roh-Johnson M, Bravo-Cordero JJ, Patsialou A, Sharma VP, Guo P, Liu H, Hodgson L, Condeelis J. Macrophage contact induces RhoA GTPase signaling to trigger tumor cell intravasation. Oncogene 2013; (Forthcoming); PMID:24056963; http://dx.doi.org/10.1038/onc.2013.377
64. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141:52-67; PMID:20371345; http://dx.doi.org/10.1016/j.cell.2010.03.015
65. Hoshino D, Jourquin J, Emmons SW, Miller T, Goldgof M, Costello K, Tyson DR, Brown B, Lu Y, Prasad NK, et al. Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis. Sci Signal 2012; 5:ra66; PMID:22969158; http://dx.doi.org/10.1126/scisignal.2002964
66. Zhang X, Nie D, Chakrabarty S. Growth factors in tumor microenvironment. [Landmark Ed]. Front Biosci (Landmark Ed) 2010; 15:151-65; PMID:20036812; http://dx.doi.org/10.2741/3612
67. Mader CC, Oser M, Magalhaes MA, Bravo-Cordero JJ, Condeelis J, Koleske AJ, Gil-Henn H. An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. Cancer Res 2011; 71:1730-41; PMID:21257711; http://dx.doi.org/10.1158/0008-5472.CAN-10-1432
68. Grass GD, Tolliver LB, Bratoeva M, Toole BP. CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness. J Biol Chem 2013; 288:26089-104; PMID:23888049; http://dx.doi.org/10.1074/jbc.M113.497685
69. Bourguignon LY, Gunja-Smith Z, Iida N, Zhu HB, Young LJ, Muller WJ, Cardiff RD. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol 1998; 176:206-15; PMID:9618160; http://dx.doi.org/10.1002/(SICI)1097-4652(199807)176:1〈206::AID-JCP22〉3.0.CO;2-3
70. Albrechtsen R, Stautz D, Sanjay A, Kveiborg M, Wewer UM. Extracellular engagement of ADAM12 induces clusters of invadopodia with localized ectodomain shedding activity. Exp Cell Res 2011; 317:195-209; PMID:20951132; http://dx.doi.org/10.1016/j.yexcr.2010.10.003
71. Abram CL, Seals DF, Pass I, Salinsky D, Maurer L, Roth TM, Courtneidge SA. The adaptor protein fish associates with members of the ADAMs family and localizes to podosomes of Src-transformed cells. J Biol Chem 2003; 278:16844-51; PMID:12615925; http://dx.doi.org/10.1074/jbc.M300267200
72. Hayes KE, Walk EL, Ammer AG, Kelley LC, Martin KH, Weed SA. Ableson kinases negatively regulate invadopodia function and invasion in head and neck squamous cell carcinoma by inhibiting an HB-EGF autocrine loop. Oncogene 2013; 32:4766-77; PMID:23146907; http://dx.doi.org/10.1038/onc.2012.513
73. Zhou ZN, Sharma VP, Beaty BT, Roh-Johnson M, Peterson EA, Van Rooijen N, Kenny PA, Wiley HS, Condeelis JS, Segall JE. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo. Oncogene 2013; (Forthcoming); PMID:24013225; http://dx.doi.org/10.1038/onc.2013.363
74. Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, Graf T, Pollard JW, Segall J, Condeelis J. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004; 64:7022-9; PMID:15466195; http://dx.doi.org/10.1158/0008-5472.CAN-04-1449
75. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124:263-6; PMID:16439202; http://dx.doi.org/10.1016/j.cell.2006.01.007
76. Lu X, Kang Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 2010; 16:5928-35; PMID:20962028; http://dx.doi.org/10.1158/1078-0432.CCR-10-1360
77. Fukumura D, Jain RK. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res 2007; 74:72-84; PMID:17560615; http://dx.doi.org/10.1016/j.mvr.2007.05.003
78. Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995; 92:5510-4; PMID:7539918; http://dx.doi.org/10.1073/pnas.92.12.5510
79. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3:721-32; PMID:13130303; http://dx.doi.org/10.1038/nrc1187
80. Subarsky P, Hill RP. The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 2003; 20:237-50; PMID:12741682; http://dx.doi.org/10.1023/A:1022939318102
81. Md Hashim NF, Nicholas NS, Dart AE, Kiriakidis S, Paleolog E, Wells CM. Hypoxia-induced invadopodia formation: a role for β-PIX. Open Biol 2013; 3:120159; PMID:23740575; http://dx.doi.org/10.1098/rsob.120159
82. rd, et al. HIF1α and HIF2α independently activate SRC to promote melanoma metastases. J Clin Invest 2013; 123:2078-93; PMID:23563312; http://dx.doi.org/10.1172/JCI66715
83. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC, Wu KJ. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 2008; 10:295-305; PMID:18297062; http://dx.doi.org/10.1038/ncb1691
84. Yamaguchi H, Takeo Y, Yoshida S, Kouchi Z, Nakamura Y, Fukami K. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells. Cancer Res 2009; 69:8594-602; PMID:19887621; http://dx.doi.org/10.1158/0008-5472.CAN-09-2305
85. Wang Y, Roche O, Xu C, Moriyama EH, Heir P, Chung J, Roos FC, Chen Y, Finak G, Milosevic M, et al. Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc Natl Acad Sci U S A 2012; 109:4892-7; PMID:22411794; http://dx.doi.org/10.1073/pnas.1112129109
86. Kaluza D, Kroll J, Gesierich S, Yao TP, Boon RA, Hergenreider E, Tjwa M, Rössig L, Seto E, Augustin HG, et al. Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin. EMBO J 2011; 30:4142-56; PMID:21847094; http://dx.doi.org/10.1038/emboj.2011.298
87. Castro-Castro A, Janke C, Montagnac G, Paul-Gilloteaux P, Chavrier P. ATAT1/MEC-17 acetyltransferase and HDAC6 deacetylase control a balance of acetylation of alpha-tubulin and cortactin and regulate MT1-MMP trafficking and breast tumor cell invasion. Eur J Cell Biol 2012; 91:950-60; PMID:22902175; http://dx.doi.org/10.1016/j.ejcb.2012.07.001
88. Rey M, Irondelle M, Waharte F, Lizarraga F, Chavrier P. HDAC6 is required for invadopodia activity and invasion by breast tumor cells. Eur J Cell Biol 2011; 90:128-35; PMID:20970878; http://dx.doi.org/10.1016/j.ejcb.2010.09.004
89. Arsenault D, Brochu-Gaudreau K, Charbonneau M, Dubois CM. HDAC6 deacetylase activity is required for hypoxia-induced invadopodia formation and cell invasion. PLoS One 2013; 8:e55529; PMID:23405166; http://dx.doi.org/10.1371/journal.pone.0055529
90. Marín-Hernández A, Gallardo-Pérez JC, Ralph SJ, Rodríguez-Enríquez S, Moreno-Sánchez R. HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 2009; 9:1084-101; PMID:19689405; http://dx.doi.org/10.2174/138955709788922610
91. McCarty MF, Whitaker J. Manipulating tumor acidification as a cancer treatment strategy. Altern Med Rev 2010; 15:264-72; PMID:21155627
92. Brisson L, Reshkin SJ, Goré J, Roger S. pH regulators in invadosomal functioning: proton delivery for matrix tasting. Eur J Cell Biol 2012; 91:847-60; PMID:22673002; http://dx.doi.org/10.1016/j.ejcb.2012.04.004
93. Xu L, Fukumura D, Jain RK. Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway: mechanism of low pH-induced VEGF. J Biol Chem 2002; 277:11368-74; PMID:11741977; http://dx.doi.org/10.1074/jbc.M108347200
94. Teti A, Grano M, Teitelbaum SL, Hruska KA, Colucci S, Zambonin Zallone A. Regulation of podosomes by intracellular pH in avian osteoclasts. Boll Soc Ital Biol Sper 1989; 65:597-601; PMID:2597415
95. Rotin D, Steele-Norwood D, Grinstein S, Tannock I. Requirement of the Na+/H+ exchanger for tumor growth. Cancer Res 1989; 49:205-11; PMID:2535690
96. Amith SR, Fliegel L. Regulation of the Na+/H+ Exchanger (NHE1) in Breast Cancer Metastasis. Cancer Res 2013; 73:1259-64; PMID:23393197; http://dx.doi.org/10.1158/0008-5472.CAN-12-4031
97. Reshkin SJ, Cardone RA, Harguindey S. Na+-H+ exchanger, pH regulation and cancer. Recent Pat Anticancer Drug Discov 2013; 8:85-99; PMID:22738122; http://dx.doi.org/10.2174/1574892811308010085
98. Lucien F, Brochu-Gaudreau K, Arsenault D, Harper K, Dubois CM. Hypoxia-induced invadopodia formation involves activation of NHE-1 by the p90 ribosomal S6 kinase (p90RSK). PLoS One 2011; 6:e28851; PMID:22216126; http://dx.doi.org/10.1371/journal.pone.0028851
99. Lucien F, Brochu-Gaudreau K, Arsenault D, Harper K, Dubois CM. Hypoxia-induced invadopodia formation involves activation of NHE-1 by the p90 ribosomal S6 kinase (p90RSK). PLoS One 2011; 6:e28851; PMID:22216126; http://dx.doi.org/10.1371/journal.pone.0028851
100. Magalhaes MA, Larson DR, Mader CC, Bravo-Cordero JJ, Gil-Henn H, Oser M, Chen X, Koleske AJ, Condeelis J. Cortactin phosphorylation regulates cell invasion through a pH-dependent pathway. J Cell Biol 2011; 195:903-20; PMID:22105349; http://dx.doi.org/10.1083/jcb.201103045
101. Busco G, Cardone RA, Greco MR, Bellizzi A, Colella M, Antelmi E, Mancini MT, Dell'Aquila ME, Casavola V, Paradiso A, et al. NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space. FASEB J 2010; 24:3903-15; PMID:20547664; http://dx.doi.org/10.1096/fj.09-149518
102. Oser M, Yamaguchi H, Mader CC, Bravo-Cordero JJ, Arias M, Chen X, Desmarais V, van Rheenen J, Koleske AJ, Condeelis J. Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. J Cell Biol 2009; 186:571-87; PMID:19704022; http://dx.doi.org/10.1083/jcb.200812176
103. Frantz C, Barreiro G, Dominguez L, Chen X, Eddy R, Condeelis J, Kelly MJ, Jacobson MP, Barber DL. Cofilin is a pH sensor for actin free barbed end formation: role of phosphoinositide binding. J Cell Biol 2008; 183:865-79; PMID:19029335; http://dx.doi.org/10.1083/jcb.200804161
104. Clark ES, Whigham AS, Yarbrough WG, Weaver AM. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 2007; 67:4227-35; PMID:17483334; http://dx.doi.org/10.1158/0008-5472.CAN-06-3928
105. Kato Y, Lambert CA, Colige AC, Mineur P, Noël A, Frankenne F, Foidart JM, Baba M, Hata R, Miyazaki K, et al. Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling. J Biol Chem 2005; 280:10938-44; PMID:15657063; http://dx.doi.org/10.1074/jbc.M411313200
106. Lin Y, Chang G, Wang J, Jin W, Wang L, Li H, Ma L, Li Q, Pang T. NHE1 mediates MDA-MB-231 cells invasion through the regulation of MT1-MMP. Exp Cell Res 2011; 317:2031-40; PMID:21669197; http://dx.doi.org/10.1016/j.yexcr.2011.05.026
107. Poincloux R, Lizárraga F, Chavrier P. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J Cell Sci 2009; 122:3015-24; PMID:19692588; http://dx.doi.org/10.1242/jcs.034561
108. Caldieri G, Buccione R. Aiming for invadopodia: organizing polarized delivery at sites of invasion. Trends Cell Biol 2010; 20:64-70; PMID:19931459; http://dx.doi.org/10.1016/j.tcb.2009.10.006
109. Steffan JJ, Snider JL, Skalli O, Welbourne T, Cardelli JA. Na+/H+ exchangers and RhoA regulate acidic extracellular pH-induced lysosome trafficking in prostate cancer cells. Traffic 2009; 10:737-53; PMID:19302267; http://dx.doi.org/10.1111/j.1600-0854.2009.00904.x
110. Luxenburg C, Geblinger D, Klein E, Anderson K, Hanein D, Geiger B, Addadi L. The architecture of the adhesive apparatus of cultured osteoclasts: from podosome formation to sealing zone assembly. PLoS One 2007; 2:e179; PMID:17264882; http://dx.doi.org/10.1371/journal.pone.0000179
111. Cougoule C, Carréno S, Castandet J, Labrousse A, Astarie-Dequeker C, Poincloux R, Le Cabec V, Maridonneau-Parini I. Activation of the lysosome-associated p61Hck isoform triggers the biogenesis of podosomes. Traffic 2005; 6: 682-94; PMID:15998323; http://dx.doi.org/10.1111/j.1600-0854.2005.00307.x
112. van Horssen R, Buccione R, Willemse M, Cingir S, Wieringa B, Attanasio F. Cancer cell metabolism regulates extracellular matrix degradation by invadopodia. Eur J Cell Biol 2013; 92:113-21; PMID:23306026; http://dx.doi.org/10.1016/j.ejcb.2012.11.003
113. Kalckar HM, Ullrey D, Kijomoto S, Hakomori S. Carbohydrate catabolism and the enhancement of uptake of galactose in hamster cells transformed by polyoma virus. Proc Natl Acad Sci U S A 1973; 70:839-43; PMID:4351806; http://dx.doi.org/10.1073/pnas.70.3.839
114. Oikawa T, Oyama M, Kozuka-Hata H, Uehara S, Udagawa N, Saya H, Matsuo K. Tks5-dependent formation of circumferential podosomes/invadopodia mediates cell-cell fusion. J Cell Biol 2012; 197:553-68; PMID:22584907; http://dx.doi.org/10.1083/jcb.201111116
115. Baron A, Migita T, Tang D, Loda M. Fatty acid synthase: a metabolic oncogene in prostate cancer? J Cell Biochem 2004; 91:47-53; PMID:14689581; http://dx.doi.org/10.1002/jcb.10708
116. Swinnen JV, Van Veldhoven PP, Timmermans L, De Schrijver E, Brusselmans K, Vanderhoydonc F, Van de Sande T, Heemers H, Heyns W, Verhoeven G. Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains. Biochem Biophys Res Commun 2003; 302:898-903; PMID:12646257; http://dx.doi.org/10.1016/S0006-291X(03)00265-1
117. Yamaguchi H, Oikawa T. Membrane lipids in invadopodia and podosomes: key structures for cancer invasion and metastasis. Oncotarget 2010; 1:320-8; PMID:21307399
118. Oikawa T, Itoh T, Takenawa T. Sequential signals toward podosome formation in NIH-src cells. J Cell Biol 2008; 182:157-69; PMID:18606851; http://dx.doi.org/10.1083/jcb.200801042
119. Oikawa T, Takenawa T. PtdIns(3,4)P2 instigates focal adhesions to generate podosomes. Cell Adh Migr 2009; 3:195-7; PMID:19262173; http://dx.doi.org/10.4161/cam.3.2.7510
120. Scott KE, Wheeler FB, Davis AL, Thomas MJ, Ntambi JM, Seals DF, Kridel SJ. Metabolic regulation of invadopodia and invasion by acetyl-CoA carboxylase 1 and de novo lipogenesis. PLoS One 2012; 7:e29761; PMID:22238651; http://dx.doi.org/10.1371/journal.pone.0029761